BCL-3 is upregulated in tissue from patients with inflammatory bowel disease (75), although further data from inflammatory bowel disease patients have shown that CpG sites in the BCL3 gene are commonly methylated and therefore repressed in B cells isolated from diseased tissue (81). This evidence concerns the gene BCL3 and inflammatory bowel disease.